Literature DB >> 16182105

Antianxiety treatment in patients with excessive hypertension.

Ehud Grossman1, Moshe Nadler, Yehonatan Sharabi, Michael Thaler, Amir Shachar, Arie Shamiss.   

Abstract

OBJECTIVE: There are no guidelines on how to treat patients with excessive hypertension. Anxiety is a common cause of excessive hypertension and therefore antianxiety treatment may be beneficial in these patients. We therefore compared the efficacy and safety of antianxiety treatment with sublingual captopril administration in patients with excessive hypertension and no evidence of acute target organ damage.
METHODS: Thirty-six patients (28 women and 8 men), mean age 60 +/- 2 years (range 36 to 85 years) who were referred to the emergency room because of excessive hypertension (>190/100 mm Hg) without evidence of acute target organ damage were randomized to receive either oral diazepam, 5 mg (n = 17, study group) or sublingual captopril, 25 mg (n = 19, control group). Blood pressure (BP) and heart rate were recorded hourly for 3 h.
RESULTS: Both treatments decreased BP significantly (from 213 +/- 5/105 +/- 3 to 170 +/- 8/88 +/- 6 mm Hg in the study group, and from 208 +/- 5/107 +/- 3 to 181 +/- 8/95 +/- 3 mm Hg in the control group (P < .01 v initial BP). One patient in each group was hospitalized because of sustained excessive hypertension.
CONCLUSIONS: Antianxiety treatment is effective in lowering BP in patients with excessive hypertension. Thus, anxiolytic treatment may be considered in patients with excessive hypertension without acute target organ damage. Further large placebo controlled studies are required to prove the benefit of anxiolytic agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182105     DOI: 10.1016/j.amjhyper.2005.03.728

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

Review 1.  Anxiety in the "age of hypertension".

Authors:  James Brian Byrd; Robert D Brook
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

Review 2.  A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths.

Authors:  Peter Kenneth Gillman
Journal:  J Neural Transm (Vienna)       Date:  2018-09-25       Impact factor: 3.575

3.  Association of normal systolic blood pressure in the emergency department with higher in-hospital mortality among hypertensive patients.

Authors:  Eyal Klang; Shelly Soffer; Moni Shimon Shahar; Yiftach Barash; Sara Apter; Eli Konen; Eyal Zimlichman; Ehud Grossman
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-19       Impact factor: 3.738

4.  Pattern of Blood Pressure Response in Patients With Severe Asymptomatic Hypertension Treated in the Emergency Department.

Authors:  Wasseem Rock; Khaled Zbidat; Naama Schwartz; Mazen Elias; Itamar Minuhin; Reuma Shapira; Ehud Grossman
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-31       Impact factor: 3.738

5.  Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies.

Authors:  Yu Pan; Wenpeng Cai; Qi Cheng; Wei Dong; Ting An; Jin Yan
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-22       Impact factor: 2.570

Review 6.  Cardiovascular therapeutics: A new potential for anxiety treatment?

Authors:  Kristina Repova; Silvia Aziriova; Kristina Krajcirovicova; Fedor Simko
Journal:  Med Res Rev       Date:  2022-01-06       Impact factor: 12.388

7.  Can Antidepressant Drug Impact on Blood Pressure Level in Patients with Psychiatric Disorder and Hypertension? A Randomized Trial.

Authors:  Seyed Kazem Razavi Ratki; Seyedmostafa Seyedhosseini; Alieh Valizadeh; Tahere Rastgoo; Rozita Tavakkoli; Allahyar Golabchi; Fatemeh Esteki Ghashghaei; Seyede Mahdieh Nemayandeh; Amirreza Boroomand; Atefeh Shirinzade
Journal:  Int J Prev Med       Date:  2016-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.